Kimberly Anne Bertrand ScD

Associate Professor, Preventive Medicine & Epidemiology

Associate Professor, Slone Epidemiology Center

72 E. Concord Street | (617) 206-6174
Kimberly Bertrand
Sections

Preventive Medicine & Epidemiology

Centers

BU-BMC Cancer Center

Biography

Dr. Bertrand’s research focuses primarily on the epidemiology of breast cancer, with an emphasis on understanding racial disparities in incidence and outcomes. She is currently Multiple Principal Investigator of the Black Women’s Health Study (BWHS), a prospective cohort study of over 59,000 African American women begun in 1995. Dr. Bertrand is also Principal Investigator of a BWHS study to evaluate risk factors for high mammographic density, a strong independent predictor of breast cancer, and the role mammographic density and other risk factors may play in tumor aggressiveness. Other areas of research interest include risk factors for non-Hodgkin lymphoma and multiple myeloma.

Other Positions

Education

Epidemiology, ScD, Harvard School of Public Health, 2010

Epidemiology, MPH, Boston University School of Public Health, 2005

Biology, BS, Brown University, 1999

Publications

Published on 4/8/2023

Harvey SV, Wentzensen N, Bertrand K, Black A, Brinton LA, Chen C, Costas L, Dal Maso L, De Vivo I, Du M, Garcia-Closas M, Goodman MT, Gorzelitz J, Johnson L, Lacey JV, Liao L, Lipworth L, Lissowska J, Miller AB, O'Connell K, O'Mara TA, Ou X, Palmer JR, Patel AV, Paytubi S, Pelegrina B, Petruzella S, Prizment A, Rohan T, Sandin S, Setiawan VW, Sinha R, Trabert B, Webb PM, Wilkens LR, Xu W, Yang HP, Zheng W, Clarke MA. Associations of life course obesity with endometrial cancer in the Epidemiology of Endometrial Cancer Consortium (E2C2). Int J Epidemiol. 2023 Apr 08. PMID: 37029916.

Published on 4/5/2023

Nichols HB, House MG, Yarosh R, Mitra S, Goldberg M, Bertrand KA, Eliassen AH, Giles GG, Jones ME, Milne RL, O'Brien KM, Palmer JR, Sandin S, Willett WC, Yin W, Sandler DP, Swerdlow AJ, Schoemaker MJ. Hypertensive conditions of pregnancy, preterm birth, and premenopausal breast cancer risk: a premenopausal breast cancer collaborative group analysis. Breast Cancer Res Treat. 2023 Jun; 199(2):323-334. PMID: 37020102.

Published on 2/10/2023

Crous-Bou M, Du M, Gunter MJ, Setiawan VW, Schouten LJ, Shu XO, Wentzensen N, Bertrand KA, Cook LS, Friedenreich CM, Gapstur SM, Goodman MT, Ibiebele TI, La Vecchia C, Levi F, Liao LM, Negri E, McCann SE, O'Connell K, Palmer JR, Patel AV, Ponte J, Reynolds P, Sacerdote C, Sinha R, Spurdle AB, Trabert B, van den Brandt PA, Webb PM, Petruzella S, Olson SH, De Vivo I. Coffee consumption and risk of endometrial cancer: a pooled analysis of individual participant data in the Epidemiology of Endometrial Cancer Consortium (E2C2). Am J Clin Nutr. 2022 Nov; 116(5):1219-1228. PMID: 36041172.

Published on 1/24/2023

Schonberg MA, Wolfson EA, Eliassen AH, Bertrand KA, Shvetsov YB, Rosner BA, Palmer JR, Ngo LH. A model for predicting both breast cancer risk and non-breast cancer death among women?>?55 years old. Breast Cancer Res. 2023 Jan 24; 25(1):8. PMID: 36694222.

Published on 1/6/2023

Sheehy S, Palmer JR, Cozier Y, Bertrand KA, Rosenberg L. Vitamin D and risk of hypertension among Black women. J Clin Hypertens (Greenwich). 2023 Feb; 25(2):168-174. PMID: 36606491.

Published on 12/19/2022

Dorgan JF, Baer HJ, Bertrand KA, LeBlanc ES, Jung S, Magder LS, Snetselaar LG, Stevens VJ, Zhang Y, Van Horn L. Childhood adiposity, serum metabolites and breast density in young women. Breast Cancer Res. 2022 Dec 19; 24(1):91. PMID: 36536390.

Published on 12/4/2022

Tanenbaum HC, Birmann BM, Bertrand KA, Teras LR, Krishnan AY, Pourhassan H, Goldsmith S, Cannavale K, Wang SS, Chao CR. Identifying monoclonal gammopathy of undetermined significance from electronic health records. Cancer Rep (Hoboken). 2023 Mar; 6(3):e1755. PMID: 36464325.

Published on 11/21/2022

Barber LE, VoPham T, White LF, Roy HK, Palmer JR, Bertrand KA. Circadian disruption and colorectal cancer incidence in Black women. Cancer Epidemiol Biomarkers Prev. 2022 Nov 21. PMID: 36409509.

Published on 10/28/2022

Brasky TM, Hade EM, Cohn DE, Newton AM, Petruzella S, O'Connell K, Bertrand KA, Cook LS, De Vivo I, Du M, Freudenheim JL, Friedenreich CM, Goodman MT, Gorzelitz J, Ibiebele TI, Krogh V, Liao LM, Lipworth L, Lu L, McCann S, O'Mara TA, Palmer JR, Ponte J, Prizment A, Risch H, Sandin S, Schouten LJ, Setiawan VW, Shu XO, Trabert B, van den Brandt PA, Webb PM, Wentzensen N, Wilkens LR, Wolk A, Yu H, Neuhouser ML. Dietary omega-3 fatty acids and endometrial cancer risk in the Epidemiology of Endometrial Cancer Consortium: An individual-participant meta-analysis. Gynecol Oncol. 2023 Feb; 169:137-146. PMID: 36934308.

Published on 10/28/2022

Brasky TM, Hade EM, Cohn DE, Newton AM, Petruzella S, O'Connell K, Bertrand KA, Cook LS, De Vivo I, Du M, Freudenheim JL, Friedenreich CM, Goodman MT, Gorzelitz J, Ibiebele TI, Krogh V, Liao LM, Lipworth L, Lu L, McCann S, O'Mara TA, Palmer JR, Ponte J, Prizment A, Risch H, Sandin S, Schouten LJ, Setiawan VW, Shu XO, Trabert B, van den Brandt PA, Webb PM, Wentzensen N, Wilkens LR, Wolk A, Yu H, Neuhouser ML. Dietary omega-3 fatty acids and endometrial cancer risk in the Epidemiology of Endometrial Cancer Consortium: An individual-participant meta-analysis. Gynecol Oncol. 2023 Feb; 169:137-146. PMID: 36934308.

View full list of 135 publications.